This inventor holds 1 USPTO granted patent. Top assignees: Dana-Farber-Cancer Institute Inc., Harvard College, The Broad Institute, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1,266 
1 out of 3,071 
1 out of 483 
Years Active: 2024
Title: Shubhroz Gill: Innovator in Cancer Treatment
Introduction
Shubhroz Gill is a notable inventor based in Cambridge, MA, who has made significant contributions to the field of cancer treatment. His innovative work focuses on developing compounds that target various proliferative diseases, particularly pancreatic cancer.
Latest Patents
Gill holds a patent for "Cyclopentaimidazolones for the treatment of cancer." This patent describes compounds that are useful in treating proliferative diseases. These compounds, along with their pharmaceutically acceptable salts, can be formulated into pharmaceutical compositions and utilized in methods for treating and preventing proliferative diseases, including cancer.
Career Highlights
Throughout his career, Shubhroz Gill has worked with prestigious organizations such as the Broad Institute, Inc. and Dana-Farber Cancer Institute Inc. His experience in these institutions has allowed him to collaborate with leading experts in the field of cancer research.
Collaborations
Some of his notable coworkers include Srivatsan Raghavan and Bruce Kuan-Yee Hua. Their collaborative efforts have contributed to advancements in cancer treatment methodologies.
Conclusion
Shubhroz Gill's innovative work in developing cancer treatment compounds highlights his commitment to addressing critical health challenges. His contributions are paving the way for new therapeutic options in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile